DE3685793T2 - Ein aminosaeurepolymer enthaltende zusammensetzung mit verzoegerter abgabe. - Google Patents

Ein aminosaeurepolymer enthaltende zusammensetzung mit verzoegerter abgabe.

Info

Publication number
DE3685793T2
DE3685793T2 DE8686306348T DE3685793T DE3685793T2 DE 3685793 T2 DE3685793 T2 DE 3685793T2 DE 8686306348 T DE8686306348 T DE 8686306348T DE 3685793 T DE3685793 T DE 3685793T DE 3685793 T2 DE3685793 T2 DE 3685793T2
Authority
DE
Germany
Prior art keywords
amino acid
polymer composition
acid polymer
delayed delivery
delayed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686306348T
Other languages
English (en)
Other versions
DE3685793D1 (de
Inventor
Rajan Bawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Application granted granted Critical
Publication of DE3685793D1 publication Critical patent/DE3685793D1/de
Publication of DE3685793T2 publication Critical patent/DE3685793T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
DE8686306348T 1985-08-16 1986-08-15 Ein aminosaeurepolymer enthaltende zusammensetzung mit verzoegerter abgabe. Expired - Lifetime DE3685793T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/766,741 US4668506A (en) 1985-08-16 1985-08-16 Sustained-release formulation containing and amino acid polymer

Publications (2)

Publication Number Publication Date
DE3685793D1 DE3685793D1 (de) 1992-07-30
DE3685793T2 true DE3685793T2 (de) 1992-12-24

Family

ID=25077389

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686306348T Expired - Lifetime DE3685793T2 (de) 1985-08-16 1986-08-15 Ein aminosaeurepolymer enthaltende zusammensetzung mit verzoegerter abgabe.

Country Status (5)

Country Link
US (1) US4668506A (de)
EP (1) EP0219208B1 (de)
JP (1) JPS62103029A (de)
CA (1) CA1277236C (de)
DE (1) DE3685793T2 (de)

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895724A (en) * 1985-06-07 1990-01-23 Pfizer Inc. Chitosan compositions for controlled and prolonged release of macromolecules
GB8529006D0 (en) * 1985-11-25 1986-01-02 Highgate D J Hydrophilic materials
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
DE3700128A1 (de) * 1987-01-03 1988-07-14 Hoechst Ag Biologisch abbaubare poly- (hydroxyalkyl)- aminodicarbonsaeure-derivate, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
US4789547A (en) * 1987-06-17 1988-12-06 Warner-Lambert Company Transdermal matrix system
US4853227A (en) * 1987-10-23 1989-08-01 Ciba-Geigy Corporation Transdermal administration of a systemic active agent to a premature neonatal infant
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5137728A (en) * 1988-03-01 1992-08-11 Bausch & Lomb Incorporated Ophthalmic article
US5149694A (en) * 1988-03-09 1992-09-22 Alcon Laboratories, Inc. Combination of tobramycin and dexamethasone for topical ophthalmic use
US5149693A (en) * 1988-03-09 1992-09-22 Alcon Laboratories, Inc. Combination of tobramycin and fluorometholone for topical ophthalmic use
WO1989009057A1 (en) * 1988-03-09 1989-10-05 Alcon Laboratories, Inc. Combination of tobramycin and steroids for topical ophthalmic use
DE3843239C1 (de) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843238C1 (de) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
MY105521A (en) * 1989-04-17 1994-10-31 Healthpoint Ltd Moisturizing vehicle for topical application of vitamin a acid.
US5252628A (en) * 1989-12-07 1993-10-12 Lions Eye Institute Of Western Australia, Inc. Method of making photoprotective hydrophilic polymers and ocular devices thereof
US5173302A (en) * 1990-09-28 1992-12-22 Medtronic, Inc. Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
CA2093282C (en) * 1992-05-04 1999-01-12 Tibor Sipos Intraoral medicament-releasing device
US5643928A (en) * 1992-10-21 1997-07-01 Pharmaco Behavioral Associates, Inc. Human body weight management
US5612357A (en) * 1992-05-18 1997-03-18 Pharmaco Behavioral Associates, Inc. Use of cotinine to assist in the cessation of tobacco smoking
US5596007A (en) * 1992-05-18 1997-01-21 Pharmaco Behavioral Associates, Inc. Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
US5869505A (en) * 1993-02-02 1999-02-09 Keenan; Robert M. Nicotine metabolites and nicotine dependence
US6162456A (en) * 1992-09-24 2000-12-19 Ortho-Mcneil Pharmaceutical, Inc. Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US5573774A (en) * 1993-02-02 1996-11-12 Keenan; Robert M. Nicotine metabolites, nicotine dependence and human body weight
US5521210A (en) * 1993-04-13 1996-05-28 Allergan, Inc. Ophthalmic use of muscarinic agonists having increased duration of activity
DE4313928C2 (de) * 1993-04-28 1996-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US5585398A (en) * 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US5612027A (en) * 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
US20060280774A1 (en) * 1995-06-02 2006-12-14 Allergan, Inc. Compositions and methods for treating glaucoma
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US5723131A (en) 1995-12-28 1998-03-03 Johnson & Johnson Vision Products, Inc. Contact lens containing a leachable absorbed material
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6410045B1 (en) 1999-02-22 2002-06-25 Clyde Lewis Schultz Drug delivery system for antiglaucomatous medication
US20020197300A1 (en) * 1999-02-22 2002-12-26 Schultz Clyde L. Drug delivery system for anti-glaucomatous medication
EP1214304B1 (de) * 1999-08-31 2005-08-24 Incyte San Diego Incorporated Benzyliden-thiazolidindione und analoga und ihre verwendung zur behandlung von diabetes
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6315987B1 (en) * 2000-05-10 2001-11-13 Isp Investments Inc. Polymeric delivery and release systems for oral care actives
US6723733B2 (en) 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
WO2001091796A2 (en) 2000-06-01 2001-12-06 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
DE10055762A1 (de) 2000-11-10 2002-06-06 Woehlk Contact Linsen Gmbh Hydrogelkontaktlinsen mit hoher Biokompatibilität
EP1339438B1 (de) * 2000-11-29 2005-10-19 Allergan Inc. Verhinderung von transplantatabstossung im auge
US20040151755A1 (en) * 2000-12-21 2004-08-05 Osman Rathore Antimicrobial lenses displaying extended efficacy, processes to prepare them and methods of their use
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
BR0207846A (pt) 2001-03-07 2005-09-13 Incyte San Diego Inc Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas
US7265139B2 (en) * 2001-03-08 2007-09-04 Incyte San Diego Inc. RXR activating molecules
CA2340824A1 (en) * 2001-03-14 2002-09-14 Ibm Canada Limited-Ibm Canada Limitee Method and system for application behavior analysis
US20030083357A1 (en) * 2001-08-17 2003-05-01 Magnus Pfahl Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
JP2005519873A (ja) * 2001-11-14 2005-07-07 アルザ・コーポレーション カテーテル注入可能なデポー組成物およびそれらの使用
EP1446099B1 (de) * 2001-11-14 2009-07-15 Durect Corporation Injizierbare depotzusammensetzungen
WO2003041684A2 (en) * 2001-11-14 2003-05-22 Alza Corporation Injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
US7071218B2 (en) 2001-11-15 2006-07-04 Incyte San Diego Incorporated N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
WO2003059965A1 (en) * 2002-01-10 2003-07-24 University Of Washington Hydrogels formed by non-covalent linkages
US7196108B2 (en) * 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
EP1482914B1 (de) * 2002-03-11 2015-04-22 Novartis AG Implantierbare arzneimittelabgabevorrichtung fürs auge
IL164822A0 (en) * 2002-04-25 2005-12-18 Rapidheal Inc Growth factor delivery system for the healing of wounds and the prevention and disease
US20030203032A1 (en) * 2002-04-25 2003-10-30 Schultz Clyde L. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
JP4183623B2 (ja) * 2002-04-26 2008-11-19 株式会社メニコン 薬剤の取り込み量が多い、薬剤徐放可能なヒドロゲル材料の製造方法
US8273366B2 (en) * 2002-06-05 2012-09-25 University Of Florida Research Foundation, Incorporated Ophthalmic drug delivery system
EP1534202B1 (de) * 2002-06-05 2009-03-11 University Of Florida Research Foundation, Inc. Ophthalmisches arzneimittelabgabesystem
US8071121B2 (en) * 2002-06-05 2011-12-06 University Of Florida Research Foundation, Incorporated Dispersions of microemulsions in hydrogels for drug delivery
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
KR20050083605A (ko) * 2002-07-31 2005-08-26 알자 코포레이션 주사 가능한 다원성 중합체 데포트 조성물 및 이의 용도
CA2494342A1 (en) * 2002-07-31 2004-02-12 Alza Corporation Injectable depot compositions and uses thereof
US7468065B2 (en) 2002-09-18 2008-12-23 Allergan, Inc. Apparatus for delivery of ocular implants
JP5238115B2 (ja) * 2002-09-18 2013-07-17 株式会社シード 薬物徐放性高分子ゲル及びそれからなる眼用レンズ
US6899717B2 (en) * 2002-09-18 2005-05-31 Allergan, Inc. Methods and apparatus for delivery of ocular implants
AU2003272575B2 (en) 2002-09-18 2007-11-08 Allergan, Inc. Methods and apparatus for delivery of ocular implants
US20040101822A1 (en) 2002-11-26 2004-05-27 Ulrich Wiesner Fluorescent silica-based nanoparticles
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2004066952A2 (en) * 2003-01-29 2004-08-12 Incyte Corporation Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
US20050208102A1 (en) * 2003-04-09 2005-09-22 Schultz Clyde L Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US20120183593A1 (en) * 2003-04-09 2012-07-19 Directcontact Llc Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US20050074497A1 (en) * 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US9216106B2 (en) * 2003-04-09 2015-12-22 Directcontact Llc Device and method for the delivery of drugs for the treatment of posterior segment disease
EP1643993A2 (de) * 2003-04-18 2006-04-12 Incyte San Diego Incorporated Substituiert isochroman-verbindungen zur behandlung von stoffwechselerkrankungen, krebs und anderen erkrankungen
JP4874795B2 (ja) * 2003-08-22 2012-02-15 ヴィスタ サイエンティフィック エルエルシー キャリヤ
US20050096311A1 (en) * 2003-10-30 2005-05-05 Cns Response Compositions and methods for treatment of nervous system disorders
WO2005044817A1 (en) 2003-11-05 2005-05-19 Sunesis Pharmaceuticals, Inc. Modulators of cellular adhesion
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
ATE418325T1 (de) 2004-01-20 2009-01-15 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon- acetonid und hyaluronsäure
US20060018949A1 (en) * 2004-04-07 2006-01-26 Bausch & Lomb Incorporated Injectable biodegradable drug delivery system
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20050244500A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intravitreal implants in conjuction with photodynamic therapy to improve vision
US8673341B2 (en) * 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US20050244472A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
US20050244471A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US8455656B2 (en) 2004-04-30 2013-06-04 Allergan, Inc. Kinase inhibitors
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US20050244458A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20050244462A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Devices and methods for treating a mammalian eye
BRPI0510485A (pt) 2004-04-30 2007-11-13 Allergan Inc implantes inibidores de tirosina cinase intravìtreos biodegradáveis
US8591885B2 (en) * 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7799336B2 (en) * 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20050244461A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Controlled release drug delivery systems and methods for treatment of an eye
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US9248614B2 (en) * 2004-06-30 2016-02-02 Novartis Ag Method for lathing silicone hydrogel lenses
EP2216026B1 (de) * 2004-07-12 2016-04-20 Allergan, Inc. Ophthalmologische Zusammensetzungen und deren Verwendung zur Behandlung von Augenkrankheiten
WO2006053186A2 (en) * 2004-11-10 2006-05-18 The Trustees Of Columbia University In The City Of New York Method for treatment of movement disorders
CN101094677A (zh) * 2004-11-15 2007-12-26 塞普泰尔公司 蛋白酪氨酸磷酸酶抑制剂及其使用方法
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
WO2006084275A2 (en) * 2005-02-04 2006-08-10 Auburn University Contact drug delivery system
US8388995B1 (en) * 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
US8349352B2 (en) * 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
DE602006006424D1 (de) * 2005-02-09 2009-06-04 Safilens S R L Ackung zur aufbewahrung und pflege einer kontaktlinse
EP1858533A4 (de) * 2005-02-22 2009-09-09 Univ Johns Hopkins Med Verwendung von amniotischer flüssigkeit (af) bei der behandlung von augenerkrankungen und verletzungen
US20060204548A1 (en) 2005-03-01 2006-09-14 Allergan, Inc. Microimplants for ocular administration
PT2444079T (pt) 2005-05-17 2017-03-03 Sarcode Bioscience Inc Composições e métodos para tratamento de distúrbios dos olhos
JP4951621B2 (ja) 2005-05-25 2012-06-13 ヒェーミシェス・インスティトゥート・シェーファー・アクチェンゲゼルシャフト 光学レンズ
US8415289B2 (en) * 2005-12-13 2013-04-09 The Trustees Of The University Of Pennsylvania Bacterial-derived BLIS for treatment of acne
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
US8668676B2 (en) * 2006-06-19 2014-03-11 Allergan, Inc. Apparatus and methods for implanting particulate ocular implants
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20070298073A1 (en) * 2006-06-23 2007-12-27 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US9039761B2 (en) 2006-08-04 2015-05-26 Allergan, Inc. Ocular implant delivery assemblies with distal caps
CN101534793A (zh) * 2006-11-06 2009-09-16 诺瓦提斯公司 眼科器件及其制造和使用方法
US20080138408A1 (en) 2006-11-13 2008-06-12 Siddharth Venkatesh Drug delivery system and method
WO2008060574A2 (en) * 2006-11-13 2008-05-22 Auburn University Therapeutic contact lenses with anti-fungal delivery
US7713541B1 (en) 2006-11-21 2010-05-11 Abbott Cardiovascular Systems Inc. Zwitterionic terpolymers, method of making and use on medical devices
WO2008064058A2 (en) * 2006-11-21 2008-05-29 Abbott Laboratories Use of a terpolymer of tetrafluoroethylene, hexafluoropropylene, and vinylidene fluoride in drug eluting coatings
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US7911053B2 (en) * 2007-04-19 2011-03-22 Marvell World Trade Ltd. Semiconductor packaging with internal wiring bus
US20080286332A1 (en) 2007-05-14 2008-11-20 Pacetti Stephen D Implantable medical devices with a topcoat layer of phosphoryl choline acrylate polymer for reduced thrombosis, and improved mechanical properties
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2170930B3 (de) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Für die behandlung von gastrointestinalen erkrankungen, entzündungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase
CA3105972A1 (en) 2007-10-19 2009-04-30 Novartis Ag Compositions and methods for treatment of diabetic retinopathy
US9849027B2 (en) 2007-11-08 2017-12-26 Alimera Sciences, Inc. Ocular implantation device
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US20090258069A1 (en) * 2008-04-15 2009-10-15 John Burnier Delivery of LFA-1 antagonists to the gastrointestinal system
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9732324B2 (en) 2008-10-23 2017-08-15 Cornell University Anti-viral method
US8545554B2 (en) * 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
PL2449379T3 (pl) 2009-07-02 2017-12-29 Sloan-Kettering Institute For Cancer Research Fluorescencyjne nanocząstki na bazie krzemionki
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
WO2011057129A2 (en) 2009-11-09 2011-05-12 Allergan, Inc. Compositions and methods for stimulating hair growth
US8980957B2 (en) 2010-01-14 2015-03-17 Cis Pharma Ag Methods for the preparation of biocompatible polymers, the polymers and their uses
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US8884027B2 (en) 2010-10-22 2014-11-11 University Of Rochester Melampomagnolide B derivatives as antileukemic and cytotoxic agents
CA2835018C (en) 2011-05-04 2020-04-21 Balance Therapeutics, Inc. Pentylenetetrazole derivatives
WO2013053856A1 (en) * 2011-10-12 2013-04-18 Ascendis Pharma A/S Prevention and treatment of ocular conditions
CA2879982C (en) 2012-07-25 2020-09-01 Sarcode Bioscience Inc. Lfa-1 inhibitor and polymorph thereof
US9827250B2 (en) 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
EP2956096A1 (de) 2013-02-15 2015-12-23 Allergan, Inc. Implantat mit langzeit-wirkstofffreisetzung
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
EP2970384A1 (de) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonisten der guanylatcyclase und deren verwendungen
EP2968439A2 (de) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Zusammensetzungen zur behandlung von magen-darm-störungen
WO2015054649A2 (en) 2013-10-10 2015-04-16 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
MX2016006142A (es) 2013-11-14 2016-12-09 Eyed Pharma Dispositivo para los ojos.
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
ES2756301T3 (es) 2014-08-19 2020-04-27 Univ California Implantes de administración localizada de fármacos y métodos de uso de los mismos
WO2016073706A1 (en) * 2014-11-06 2016-05-12 Board Of Regents, The University Of Texas System Delivery of small interfering rna and micro rna through nanogels containing hydrophobic pseudo-peptides
WO2016178151A1 (en) 2015-05-04 2016-11-10 Ecole Polytechnique Federale De Lausanne (Epfl) Ophthalmic contact lens with a compressible affinity matrix
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
EP3356433B1 (de) 2015-10-02 2019-09-18 CIS Pharma AG Neue polymermaterialien für kontaktlinsenanwendungen
GB201523102D0 (en) * 2015-12-30 2016-02-10 Augmented Optics Ltd Electrically active hydrophilic bio-polymers
CA3009814A1 (en) 2016-01-11 2017-07-20 Synergy Pharmaceuticals, Inc. Formulations and methods for treating ulcerative colitis
PT109154B (pt) 2016-02-12 2019-11-05 Univ De Coimbra Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
US11634400B2 (en) 2017-08-19 2023-04-25 University Of Rochester Micheliolide derivatives, methods for their preparation and their use as anticancer and antiinflammatory agents
WO2019090117A1 (en) 2017-11-03 2019-05-09 The Regents Of The University Of California Methods of implanting a device into a brain
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11338119B2 (en) 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
JP7349578B2 (ja) 2020-10-27 2023-09-22 エルシダ オンコロジー， インコーポレイテッド 葉酸受容体に標的化されたナノ粒子薬物コンジュゲートおよびその使用
IL308458A (en) 2021-07-07 2024-01-01 Genentech Inc Rod insertion system and methods
WO2023178302A1 (en) 2022-03-18 2023-09-21 University Of Rochester Parthenolide derivatives and use thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
NL128305C (de) * 1963-09-11
AT251910B (de) * 1964-07-02 1967-01-25 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von weichen, biegsamen Kontaktlinsen
DE1617393C2 (de) * 1966-01-06 1982-11-11 Československá akademie věd, Praha Verfahren zur Herstellung von biologisch aktive Stoffe enthaltenden hydrophilen vernetzten Copolymeren
US3557261A (en) * 1967-10-05 1971-01-19 Ceskoslovenska Akademie Ved Method of centrifugally casting layered contact lenses
US3825458A (en) * 1968-03-06 1974-07-23 Ceskoslovenska Akademie Ved Method of making hydrogel laminates
US3822089A (en) * 1968-09-25 1974-07-02 Akademie Ved Contact lens blank or replica made from anhydrous, sparingly cross-linked hydrophilic copolymers
US3618604A (en) * 1969-06-09 1971-11-09 Alza Corp Ocular insert
CS159361B1 (de) * 1970-09-08 1975-01-31
US3857932A (en) * 1970-09-09 1974-12-31 F Gould Dry hydrophilic acrylate or methacrylate polymer prolonged release drug implants
US3641237A (en) * 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
GB1391438A (en) * 1971-04-20 1975-04-23 Contact Lens Mfg Ltd Hydrophilic copolymers and articles formed therefrom
US3826258A (en) * 1972-02-07 1974-07-30 S Abraham Gradual release medicine carrier
US3786812A (en) * 1972-03-10 1974-01-22 C Neefe Contact lens for olar drug delivery
US3811444A (en) * 1972-12-27 1974-05-21 Alza Corp Bioerodible ocular device
DE2364675C2 (de) * 1972-12-29 1983-06-23 Kuraray Co., Ltd., Kurashiki, Okayama Aus einer Polymerenhauptkette und Polymerenseitenketten bestehendes Copolymeres und seine Verwendung zur Herstellung von Gegenständen für biomedizinische Zwecke
US4003991A (en) * 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
US4143949A (en) * 1976-10-28 1979-03-13 Bausch & Lomb Incorporated Process for putting a hydrophilic coating on a hydrophobic contact lens
JPS5374049A (en) * 1976-11-04 1978-07-01 Toray Industries Soft contact lens material
US4153641A (en) * 1977-07-25 1979-05-08 Bausch & Lomb Incorporated Polysiloxane composition and contact lens
US4182802A (en) * 1977-12-27 1980-01-08 Samuel Loshaek Hydrophilic polymers and contact lenses of high water content
US4158089A (en) * 1977-12-27 1979-06-12 Wesley-Jessen Inc. Contact lenses of high water content
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4157418A (en) * 1978-02-08 1979-06-05 Minnesota Mining And Manufacturing Company Acrylic functional aminocarboxylic acids and derivatives as components of pressure sensitive adhesives
US4152508A (en) * 1978-02-15 1979-05-01 Polymer Technology Corporation Silicone-containing hard contact lens material
CS216992B1 (en) * 1980-07-21 1982-12-31 Miroslav Stol Composite polymere material for the biological and medicinal utilitation and method of preparation thereof
GB2087408B (en) * 1980-11-04 1984-05-23 Patel Pravin Gordhanbhai Da Co Cross-linked hydrophilic polymers
US4462665A (en) * 1981-01-29 1984-07-31 The Kendall Company Composite hydrogel-forming lens and method of making same
US4440919A (en) * 1981-11-12 1984-04-03 Bausch & Lomb Incorporated Low N-vinyl lactam content based biomedical devices
US4436887A (en) * 1981-11-12 1984-03-13 Bausch & Lomb Incorporated N-Vinyl lactam based biomedical devices
JPS58134019A (ja) * 1982-02-05 1983-08-10 Ono Pharmaceut Co Ltd プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法
US4495361A (en) * 1983-04-29 1985-01-22 Bausch & Lomb Incorporated Polysiloxane composition with improved surface wetting characteristics and biomedical devices made thereof
US4548990A (en) * 1983-08-15 1985-10-22 Ciba-Geigy Corporation Crosslinked, porous polymers for controlled drug delivery
CS239282B1 (en) * 1983-08-17 1986-01-16 Otto Wichterle Preparation method of objects made from hydrophilic gelsnamely contact lences by polymer casting
US4536554A (en) * 1984-02-22 1985-08-20 Barnes-Hind, Inc. Hydrophilic polymers and contact lenses made therefrom

Also Published As

Publication number Publication date
EP0219208B1 (de) 1992-06-24
EP0219208A3 (en) 1988-06-01
DE3685793D1 (de) 1992-07-30
CA1277236C (en) 1990-12-04
EP0219208A2 (de) 1987-04-22
US4668506A (en) 1987-05-26
JPS62103029A (ja) 1987-05-13

Similar Documents

Publication Publication Date Title
DE3685793T2 (de) Ein aminosaeurepolymer enthaltende zusammensetzung mit verzoegerter abgabe.
DE3683144D1 (de) Pflaster mit verzoegerter abgabe.
DE3681579D1 (de) Schubsteckverbinder mit langer lebensdauer.
DE3680401D1 (de) Rtv-siliconpasten mit verkuerzter aushaertungszeit.
DE3586823D1 (de) Matrize fuer bioaktive zusammensetzung mit dauerverabreichung.
DE3688532T2 (de) Pharmazeutische darreichungsform mit verzoegerter abgabe.
DE3687403D1 (de) Harzzusammensetzung.
NO860314L (no) Stigeroersystem.
DE68905387D1 (de) Aminosaeure-nahrungsmittelzusammensetzungen.
NO881338D0 (no) Injeksjonsroer.
DE3687868D1 (de) Formulierung mit verzoegerter wirkstoffabgabe, die ein aminosaeurepolymer und ein polares niedrigalkyl(c1-c4)-loesungsmittel enthaelt.
DE68915207T2 (de) Aminosäure-Derivate.
DE3676895D1 (de) Verbindungssystem fuer terminals mit speicher.
DE3680659D1 (de) Thermoplastische harzzusammensetzung.
DE3687062T2 (de) Polymerzusammensetzung mit positiven temperaturkoeffizienten-charakteristiken.
NO167321C (no) Roerkobling.
DE3688691T2 (de) Salzbeständige Polyamidzusammensetzung.
DE3484584D1 (de) Injektionen mit verzoegerter abgabe.
DE3688458T2 (de) Polymerzusammensetzung.
DE3671132D1 (de) Flache zelle.
NO862790D0 (no) Roerkobling.
DE3787657T2 (de) Aminosäure-Derivate.
DE58905155D1 (de) Polyacrylsaeureester mit quaternaeren ammoniumgruppen.
FI860342A0 (fi) Polymeriserbara kompositioner.
DE3688309T2 (de) Polyamidzusammensetzung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee